title: Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection.
abstract: Chemokines and cytokines play a vital role in directing and regulating immune responses to viral infections. Persistent hepatitis C virus (HCV) infection is characterized by the loss of anti-HCV cellular immune responses, while control of HCV infection is associated with maintenance of anti-HCV cellular immune responses. To determine whether plasma concentrations of 19 chemokines and cytokines controlling T-cell trafficking and function differed based on infection outcome, we compared them in at-risk subjects followed prospectively for HCV infection. Levels were compared over time in subjects who controlled HCV infection (Clearance) and subjects who developed persistent HCV infection (Persistence) at two time points during acute infection: (i) first viraemic sample (initial viraemia) and (ii) last viraemic sample in Clearance subjects and time-matched samples in Persistence subjects. At initial viraemia, increased pro-inflammatory tumour necrosis factor α (TNFα) plasma concentrations were observed in the Clearance group, while the plasma levels of anti-inflammatory interleukin (IL)-2, IL-10 and IL-13 were higher in the Persistence group. IL-13 was positively correlated with IL-2 and IL-10 at initial viraemia in the Persistence group. At the time of last viraemia, plasma levels of eotaxin, macrophage chemoattractant protein-4 (MCP-4), IL-5 and IL-10 were higher in the Persistence group and IL-10 and IL-5 levels were positively correlated. Collectively, these results suggest that the development of persistent infection is associated with an anti-inflammatory and pro-fibrogenic chemokine and cytokine profile that is evident at the onset of infection and maintained throughout acute infection.
authors: Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
authors: W O
authors: WO
authors: Osburn
authors: J S
authors: JS
authors: Levine
authors: M A
authors: MA
authors: Chattergoon
authors: D L
authors: DL
authors: Thomas
authors: A L
authors: AL
authors: Cox
mesh_terms: D000208:Acute Disease; D000328:Adult; D002465:Cell Movement; D054413:Chemokine CCL11 / Q000097:blood; D005260:Female; D016174:Hepacivirus; D006526:Hepatitis C / Q000276:immunology* / Q000473:pathology; D006801:Humans; D016753:Interleukin-10 / Q000097:blood*; D015848:Interleukin-5 / Q000097:blood*; D008137:Longitudinal Studies; D008297:Male; D018945:Monocyte Chemoattractant Proteins / Q000097:blood*; D011446:Prospective Studies; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000097:blood*; D014766:Viremia / Q000276:immunology
chemical_list: C099677:CCL13 protein, human; D054413:Chemokine CCL11; C508609:IL10 protein, human; D015848:Interleukin-5; D018945:Monocyte Chemoattractant Proteins; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10
references: Clin Exp Immunol. 2006 May;144(2):188-96
references: 16634790
references: Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6
references: 12761383
references: Science. 1995 Jun 9;268(5216):1472-6
references: 7770771
references: J Immunol. 1997 Jun 1;158(11):5536-44
references: 9164978
references: Immunol Rev. 2001 Feb;179:163-72
references: 11292020
references: J Asthma. 2004 Feb;41(1):27-33
references: 15046375
references: Hepatology. 2003 Oct;38(4):859-68
references: 14512873
references: J Virol. 2008 May;82(10):5043-53
references: 18337568
references: Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):586-90
references: 14699044
references: Hepatology. 1996 Jul;24(1):6-9
references: 8707283
references: Clin Infect Dis. 2005 Apr 1;40(7):951-8
references: 15824985
references: J Immunol. 1997 Nov 15;159(10):4772-80
references: 9366401
references: Arthritis Rheum. 2009 Jul;60(7):1932-43
references: 19565514
references: J Med Virol. 2003 Sep;71(1):31-40
references: 12858406
references: Gastroenterology. 2010 Jan;138(1):315-24
references: 19782080
references: Hepatology. 2004 Nov;40(5):1062-71
references: 15486925
references: Hepatology. 2009 Apr;49(4):1335-74
references: 19330875
references: Hepatology. 2005 Jul;42(1):104-12
references: 15962289
references: J Virol. 2005 Jun;79(12):7860-7
references: 15919940
references: Gut. 2006 Mar;55(3):374-9
references: 16150856
references: J Allergy Clin Immunol. 2007 Jul;120(1):76-83
references: 17531298
references: J Immunol. 2002 Nov 1;169(9):4850-60
references: 12391195
references: Wkly Epidemiol Rec. 1997 Nov 14;72(46):341-4
references: 9385865
references: J Gastroenterol Hepatol. 2007 Aug;22(8):1256-64
references: 17688666
references: Dig Dis Sci. 2011 Apr;56(4):1057-64
references: 20848204
references: J Infect Dis. 2011 Dec 1;204(11):1730-40
references: 21984735
references: Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54
references: 15220475
references: Proc Natl Acad Sci U S A. 1987 Oct;84(19):6629-33
references: 3498940
references: Hepatol Res. 2011 Jun;41(6):587-93
references: 21504519
references: Gastroenterology. 2009 Jun;136(7):2377-86
references: 19303013
references: Hepatology. 2012 Jun;55(6):1684-91
references: 22234804